Arteris, Inc.·4

Jun 4, 7:00 PM ET

Kunkel Joachim 4

4 · Arteris, Inc. · Filed Jun 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Arteris (AIP) Director Joachim Kunkel Receives RSU Award

What Happened
Joachim Kunkel, a director of Arteris, Inc. (AIP), was granted 4,703 restricted stock units (RSUs) on June 2, 2026. The Form 4 reports an acquisition (award) of 4,703 RSUs at $0.00 (award price); the company used an average trading price of $31.89 (Apr 21–Jun 2, 2026) to value the grant at about $149,979. The reporting person elected to defer receipt of the shares.

Key Details

  • Transaction date: June 2, 2026; Form 4 filed June 4, 2026 (no late filing indicated).
  • Award reported as acquisition (code A) of 4,703 RSUs at $0.00; FMV used for valuation: $31.89 per share → ≈ $149,979 total.
  • Vesting: RSUs vest in full on the earlier of (i) the first anniversary of the grant date or (ii) immediately before the issuer’s next annual meeting, subject to continued board service. RSUs have no expiration date.
  • Reporting person elected to defer receipt of the shares (footnote).
  • Shares owned after the transaction: not disclosed in the provided filing.

Context
RSUs are a form of equity award that convert to common shares upon vesting; this is an award (acquisition) rather than an open-market purchase or sale. Awards to directors are common as compensation for service and do not by themselves indicate buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-06-02
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-06-02+4,70374,330 total
Footnotes (2)
  • [F1]The Reporting Person elected to defer the receipt of shares.
  • [F2]Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89.
Signature
/s/ Paul Alpern as Attorney-in-fact for Joachim Kunkel|2026-06-04

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT